Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS

B. Weinstock-Guttman, S.L. Galetta, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, P.W. O'Connor, J.T. Phillips, C.H. Polman, W.H. Stuart, F. Lynn, C. Hotermans

Research output: Contribution to journalArticleAcademicpeer-review

56 Citations (Scopus)
Original languageEnglish
Pages (from-to)898-905
JournalJournal of neurology
Issue number5
Publication statusPublished - 2012

Cite this